Home > Boards > US Listed > Miscellaneous > Rigel Pharmaceuticals Inc. (RIGL)

7:40AM On The Wires (WIRES) :

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 439
Posts 21,503
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Rigel Initiates Phase 3 Studies of Fostamatinib in ITP "PR Newswire (US)" - 7/16/2014 8:35:00 AM
Rigel Initiates Phase 3 Studies of Fostamatinib in ITP "PR Newswire (US)" - 7/16/2014 7:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 6/5/2014 4:06:26 PM
Rigel to Present at Jefferies 2014 Global Healthcare Conference "PR Newswire (US)" - 5/29/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/27/2014 4:16:20 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2014 5:53:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2014 5:49:20 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2014 5:48:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2014 5:46:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2014 5:45:31 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/7/2014 4:45:43 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/7/2014 1:47:55 PM
Rigel Announces First Quarter 2014 Financial Results "PR Newswire (US)" - 5/7/2014 7:30:00 AM
Rigel Announces Webcast of Investor Day on May 6, 2014 "PR Newswire (US)" - 4/30/2014 7:30:00 AM
Health Care Sector Stocks under Review -- Research on Sanofi, Impax Laboratories, Keryx Biopharma, and Rigel Pharma "PR Newswire (US)" - 4/8/2014 1:59:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/21/2014 4:16:25 PM
Health Care Equities Analysis -- Research on Keryx Biopharma, Rigel Pharma, Sanofi and Impax Laboratories "PR Newswire (US)" - 3/19/2014 8:41:00 AM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] "Edgar (US Regulatory)" - 3/12/2014 6:18:20 PM
Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ... "PR Newswire (US)" - 3/10/2014 12:30:00 PM
Rigel Announces Publication of R118 AMPK Activator Research "PR Newswire (US)" - 3/6/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/5/2014 5:31:30 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/4/2014 2:01:45 PM
Rigel Announces Fourth Quarter and Year End 2013 Financial Results "PR Newswire (US)" - 3/4/2014 7:30:00 AM
Rigel Announces Participation at Two Investor Conferences "PR Newswire (US)" - 2/27/2014 7:30:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/14/2014 5:28:26 PM
surf1944   Friday, 05/06/11 09:58:11 AM
Re: surf1944 post# 130
Post # of 271 
7:40AM On The Wires (WIRES) :

Rigel Pharmaceuticals, Inc. (RIGL) announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer (PFE) is returning full rights to the R343 program as a result of its decision to exit the allergy and respiratory therapeutic area within R&D. Rigel is evaluating the details of R343's development to date and expects to design a Phase 2 clinical trial with R343 later this year.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist